Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial.

@article{Fleischer2010EndoscopicRA,
  title={Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial.},
  author={David E. Fleischer and Bergein F. Overholt and V K Sharma and Alvaro Reymunde and Michael B. Kimmey and Ram Chuttani and K. J. Chang and R Muthasamy and Charles J. Lightdale and Nilda Santiago and Douglas K. Pleskow and Patrick J. Dean and K. K. Wang},
  journal={Endoscopy},
  year={2010},
  volume={42 10},
  pages={
          781-9
        }
}
BACKGROUND AND STUDY AIMS The AIM-II Trial included patients with nondysplastic Barrett's esophagus (NDBE) treated with radiofrequency ablation (RFA). Complete eradication of NDBE (complete response-intestinal metaplasia [CR-IM]) was achieved in 98.4 % of patients at 2.5 years. We report the proportion of patients demonstrating CR-IM at 5-year follow-up. PATIENTS AND METHODS Prospective, multicenter US trial (NCT00489268). After endoscopic RFA of NDBE up to 6 cm, patients with CR-IM at 2.5… 

Figures and Tables from this paper

Radiofrequency Ablation in Patients with Barrett's Esophagus- related Neoplasia - Long-Term Outcomes in the Czech National Database.

TLDR
RFA is highly effective in achieving remission in patients with BORN and a significant proportion of patients did not achieve CR-IM or had a recurrence of IM despite macroscopically absent BE, so patients after successful RFA still require endoscopic surveillance.

Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.

TLDR
Among patients who have undergone RFA with or without endoscopic resection for neoplastic BE, 90% remain in remission at 5-year follow-up, with all recurrences managed endoscopically.

Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis.

  • Eric S. OrmanNan LiN. Shaheen
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2013

Intestinal Metaplasia Recurs Infrequently in Patients Successfully Treated for Barrett's Esophagus With Radiofrequency Ablation

TLDR
In patients with BE and dysplasia or early cancer who achieved CE-IM, BE recurred in ∼5%/year, and subjects undergoing RFA for dysplastic BE should be retained in endoscopic surveillance.

Durability and predictors of successful radiofrequency ablation for Barrett's esophagus.

  • S. PasrichaW. Bulsiewicz N. Shaheen
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2014

Radiofrequency Ablation for Barrett’s Esophagus: The 10 Year Experience at a Single Center

TLDR
At the authors' tertiary center, radiofrequency ablation was confirmed to be an effective and safe ablative technique eradicating dysplastic Barrett’s esophagus and Complications rates were low with development of stricture being most common.

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.

TLDR
In subjects with dysplastic BE, RFA therapy has an acceptable safety profile, is durable, and is associated with a low rate of disease progression, for up to 3 years.

Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.

TLDR
Of patients with BE treated by RFA, 56% were in complete remission after 24 months, however, 33% of these patients had disease recurrence within the next 2 years, but continued surveillance after RFA is essential.

Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett’s Esophagus With Radiofrequency Ablation

TLDR
Most patients with recurrent BE after initially successful RFA achieve second CE-IM; however, 1.8% progressed to invasive adenocarcinoma.
...

References

SHOWING 1-10 OF 49 REFERENCES

Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry.

TLDR
In this multicenter registry conducted at four community-based practices, the observed safety and efficacy outcomes associated with RFA for Barrett's esophagus are comparable to those previously reported in multicenter trials from predominantly tertiary academic centers.

Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia.

TLDR
Barrett's eradication rates were comparable to previously published reports and one case of buried Barrett's metaplasia was identified out of 247 biopsies and was eradicated with repeat ablation.

Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.

  • R. PouwK. Wirths J. Bergman
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2010

A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).

TLDR
A stepwise regimen of circumferential ablation followed by focal ablation appears to eradicate intestinalmetaplasia and dysplasia at 2-year follow-up in this trial, without stricture formation or buried intestinal metaplasia.

Esophageal Adenocarcinoma in Barrett's Esophagus After Endoscopic Ablative Therapy: A Meta-Analysis and Systematic Review

TLDR
Compared to historical reports of the natural history of BE, ablation may be associated with a reduction in cancer incidence, although such a comparison is limited by likely heterogeneity between treatment and natural history studies.

Eradication of Barrett Esophagus with Early Neoplasia by Radiofrequency Ablation, with or without Endoscopic Resection

TLDR
Radiofrequency ablation, with or without prior endoscopic resection for visible abnormalities, is effective and safe in eradicating BE and associated neoplasia.

Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia

TLDR
Stepwise circumferential and focal ablation of BE containing Dysplasia appears to be a safe and effective intervention, achieving a CR for dysplasia in 95% and 79% of LGD and HGD patients, respectively.